Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

Polaris AI Pharma Corp.

폴라리스AI파마041910KOSDAQSector: Pharma & Biotech
₩5,4400.74%Market cap ₩72.3BAs of Sep 1, 2026 close · updated once daily
Market cap
₩72.3B
#925 in KOSDAQ
11.6x
Sector median 16.1x (profitable cos.)
0.53x
Sector median 1.59x
0.0%
Sector median 0.0%
A
Grade A66.9 ptsTop 17% of 2,523 graded stocksMethodology v2.0
Financial strength
66.2/100
Growth momentum
48.5/100
Price attractiveness
85.4/100
Shareholder Return
37.5/100

As of Sep 1, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SACurrentBCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band A with a total score of 66.9 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩4,300High ₩8,920
Latest close
Price change by period
1W
2.40%
1M
5.60%
3M
5.50%
1Y
11.40%

As of the Sep 1, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

66.2/100
How much debt does it carry relative to equity?
44.1%
Sector median 51.6%
Sector lowhighTop 41.5% in sector
Can it cover what's due within a year?
261.5%
Sector median 191.7%
Sector lowhighTop 37.9% in sector
How much of revenue becomes profit?
5.7%
Sector median -2.4%
Sector lowhighTop 26.8% in sector
How much did it earn on its own capital?
4.5%
Sector median -4.5%
Sector lowhighTop 28.9% in sector

Source filing: annual report (separate) — view original ↗

2

Growth momentum

48.5/100
How much did revenue grow in a year?
-6.8%
Sector median 6.4%
Sector lowhighBottom 23% in sector
Has it grown steadily over three years?
-3.6%
Sector median 4.9%
Sector lowhighBottom 25% in sector
Did core profits grow in a year?
1712.2%
Sector median 3.6%
Sector lowhighTop 1.1% in sector
Are core profits higher than three years ago?
0.9%
Sector median 3.5%
Sector lowhighBottom 47% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (separate) — view original ↗

3

Price attractiveness

85.4/100
Is the price expensive relative to earnings?
11.6x
Sector median P/E of profitable peers 16.1x · 58% loss-making
Sector lowhighTop 16% in sector
Is the price expensive relative to book value?
0.53x
Sector median 1.59x
Sector lowhighTop 13.2% in sector

Valuation uses the Sep 1, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Treasury shares (FY2025)
218,257 shares (1.6% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (separate) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 1, 2026

Of 9 items: 6 met · 3 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩6.2B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩8.8B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
3.2% → 4.6%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩8.8B vs ₩6.2B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Not met
4.4% → 30.6%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Not met
1658.2% → 261.5%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
13,501,607 → 13,501,607
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
0.3% → 5.7%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not met
0.49x → 0.41x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (separate) — view original ↗

Grade change history

Jul 23, 2026A

Methodology version change (v2.0 applied)

Jul 15, 2026AVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

CB with conversion-price adjustment clause (past 36 months)

1 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2026-03-26). View filing ↗

CEO (representative executive officer) change filings (past 36 months)

3 CEO (representative executive officer) change filings were submitted in the past 36 months (latest filing 2026-03-23). View filing ↗

Determined as of 2026-09-01

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source ↗
Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →